PM Modi condoles death of Prof Ved Prakash Nanda, prominent member of Indian diaspora in US

-

Prime Minister Narendra Modi Tuesday expressed his condolences over the passing away of Professor Ved Prakash Nanada, a prominent member of the Indian diaspora in the US.

Offering his condolences to the family members of Nanda, PM Modi said he was passionate about strong India-USA relations.

“Deeply saddened by the passing away of Professor Ved Prakash Nanda Ji, a distinguished academic whose contributions to the legal field are invaluable. His work highlights his strong commitment to legal education. He was also a prominent member of the Indian diaspora in USA and was passionate about strong India-USA relations. Condolences to his family and friends. Om Shanti,” PM Modi said in a post on X, formerly known as Twitter.

Who was Ved Prakash Nanda?

Nanda, an Indian-American academic, passed away on 2 January, 2024. He was serving as a John Evans Distinguished University Professor at the University of Denver, Colorado in the US.

He was also the Founding Director and Director Emeritus, International Legal Studies Program; and Director of Ved Nanda Center for International and Comparative Law, University of Denver Sturm College of Law.

He had also served as Vice President of the American Society of International Law.

Professor Nanda played crucial roles in the Indian diaspora in the USA for more than four decades. He has significantly contributed to the diplomatic ties between India and the US and his advocacy for strong relations between both the nations spanned three decades.

Nanda was awarded with Padma Bhushan in 2018 for his contributions to literature and education.

Back in 2006, Prof Nanda was honored with a $1 million founding gift from University of Denver alumni Doug and Mary Scrivner to launch the Ved Nanda Center for International and Comparative Law.

The Center began its academic endeavors in 2007, hosting programs for the lawyers, students, and community participants as well as promoting scholarship in the field of international law.

With inputs from agencies



from Firstpost India Latest News https://ift.tt/CDo3ayN
Umang Sharma

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more